Curriculum
1.75 CME Credit
Where Are We Now? The Integral Role of GLP-1 RAs in the Treatment of Type 2 Diabetes Mellitus
This is your one-stop shopping for a comprehensive understanding of GLP-RAs and how to incorporate them into clinical practice. The endured PrimaryCareNOW session provides foundational knowledge and the 3-part Case Conversations podcast series offer real-world case examples with practical advice on how to use GLP-1 RAs to best effect in your patients while troubleshooting potential challenges.
CME Information
1.75 AMA PRA Category 1 Credits™, 1.75 ABIM MOC or 2.09 AANP, including 2.09 AANP Pharm
Release Date: 8/29/2022
Available for credit until 9/21/2023
Topics
Learning Objectives
- Review the mechanism of action (MOA), administration, and indications of the various glucagon-like peptide-1 receptor agonists (GLP-1 RA) available for the treatment of type 2 diabetes mellitus (T2DM)
- Describe the data from clinical trials showing the benefits of GLP-1 RA including those beyond glycemic control
- Summarize guidelines around the use of GLP-1 RA, highlighting recent changes which encourage earlier initiation in diabetes care and consideration of comorbidities
- Outline how to use patient-centered care to approach common barriers in developing and adjusting a diabetes care management plan
Courses
Virtual CME Program
Where Are We Now? The Integral Role of GLP-1 RAs in the Treatment of Type 2 Diabetes Mellitus
1.00 CME/MOC
1.00 AANP | 1.00 Pharmacology
Podcast
Struggling with Weight Loss: Case Conversations in Type 2 Diabetes
0.25 CME/MOC
0.35 AANP | 0.35 Pharmacology
Podcast
To Add Insulin or Not to Add Insulin: Case Conversations in Type 2 Diabetes
0.25 CME/MOC
0.37 AANP | 0.37 Pharmacology
Podcast
Avoiding Treatment Delays: Case Conversations in Type 2 Diabetes
0.25 CME/MOC
0.37 AANP | 0.37 Pharmacology
Faculty Disclosures
Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC
President and Owner
Diabetes Consulting Services
North Bethesda, MD
Tina K. Thethi, MD, MPH
Associate Investigator and Endocrinologist
AdventHealth Translational Research Institute
Orlando, FL
CME Information
AMA PRA Category 1 Credits™
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Pri-Med Institute and American Kidney Fund. Pri-Med Institute is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement
Pri-Med Institute designates this endured activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AANP
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Pri-Med Institute and American Kidney Fund. Pri-Med Institute is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement
This activity is approved for 1.03 contact hour of continuing education, which includes 0.00 hour of pharmacology.
Supporters and Partners
Commercial Supporters
Novo Nordisk Inc.
Education Partners
Pri-Med Institute
Fine Print
The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.
The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, or DBC Pri-Med, LLC.
Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.
Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP. Pri-Med Institute is the accredited provider for this activity.
Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME activities to disclose relevant personal financial relationships with commercial interests prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to resolve real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. Financial disclosures are listed in the activity syllabus and will also be printed on the slides and announced at the start of each presentation.
Pri-Med Institute and Vindico Medical Education staff have no relevant financial relationships to disclose.
Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.
Questions?
If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.
Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Essential Areas and Policies. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.
The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.